[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fN_kLPdgvlmrSml9WrHtFZWYIWh97XocS3phNiTI9djE":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":42,"rows":49},"Sheffield Children's NHS Foundation Trust",[4],51,false,10,1,2964,3,46,[14,16,19,21,23,25,27,29],{"name":15,"count":11},"Fractures, Bone",{"name":17,"count":18},"Osteogenesis Imperfecta",2,{"name":20,"count":18},"Bone Fracture",{"name":22,"count":18},"Fracture",{"name":24,"count":18},"Sleep Apnea",{"name":26,"count":9},"Leg Length Inequality",{"name":28,"count":9},"Foot Deformities",{"name":30,"count":9},"SMA - Spinal Muscular Atrophy",[32,37],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT03514589","NeSST2: The Development of a Noninvasive Short Synacthen Test","2025-12-01","nasal Tetracosactide",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT07402707","Dosing of Steroids for Acute Asthma Given in the Emergency Department - a Pilot Randomised Feasibility Trial of Dexamethasone in Children","2026-08-31","dexamethasone",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,74,96,114,139,164],{"intervention":41,"totalTrials":9,"cells":51},{"EARLY_PHASE1":52,"PHASE1":55,"PHASE2":57,"PHASE3":59,"PHASE4":61,"NA":72},{"trials":53,"activeCount":54},[],0,{"trials":56,"activeCount":54},[],{"trials":58,"activeCount":54},[],{"trials":60,"activeCount":54},[],{"trials":62,"activeCount":9,"soonestReadout":40},[63],{"nctId":38,"briefTitle":39,"status":64,"phases":65,"primaryCompletion":40,"completion":40,"start":66,"enrollment":67,"conditions":68,"interventions":71},"RECRUITING",[47],"2026-02-23",104,[69,70],"Acute Asthma","Dexamethasone",[41],{"trials":73,"activeCount":54},[],{"intervention":36,"totalTrials":9,"cells":75},{"EARLY_PHASE1":76,"PHASE1":78,"PHASE2":80,"PHASE3":90,"PHASE4":92,"NA":94},{"trials":77,"activeCount":54},[],{"trials":79,"activeCount":54},[],{"trials":81,"activeCount":9,"soonestReadout":35},[82],{"nctId":33,"briefTitle":34,"status":64,"phases":83,"primaryCompletion":35,"completion":35,"start":84,"enrollment":85,"conditions":86,"interventions":88},[45],"2012-10-12",12,[87],"Adrenal Suppression",[36,89],"IV tetracosactide",{"trials":91,"activeCount":54},[],{"trials":93,"activeCount":54},[],{"trials":95,"activeCount":54},[],{"intervention":89,"totalTrials":9,"cells":97},{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":108,"PHASE4":110,"NA":112},{"trials":99,"activeCount":54},[],{"trials":101,"activeCount":54},[],{"trials":103,"activeCount":9,"soonestReadout":35},[104],{"nctId":33,"briefTitle":34,"status":64,"phases":105,"primaryCompletion":35,"completion":35,"start":84,"enrollment":85,"conditions":106,"interventions":107},[45],[87],[36,89],{"trials":109,"activeCount":54},[],{"trials":111,"activeCount":54},[],{"trials":113,"activeCount":54},[],{"intervention":115,"totalTrials":9,"cells":116},"Botox",{"EARLY_PHASE1":117,"PHASE1":119,"PHASE2":121,"PHASE3":123,"PHASE4":125,"NA":137},{"trials":118,"activeCount":54},[],{"trials":120,"activeCount":54},[],{"trials":122,"activeCount":54},[],{"trials":124,"activeCount":54},[],{"trials":126,"activeCount":54},[127],{"nctId":128,"briefTitle":129,"status":130,"phases":131,"primaryCompletion":132,"completion":133,"start":134,"enrollment":54,"conditions":135,"interventions":136},"NCT00624299","Botox Clinical Trial","WITHDRAWN",[47],"2010-03","2010-05","2008-03",[26,28],[115],{"trials":138,"activeCount":54},[],{"intervention":140,"totalTrials":9,"cells":141},"Risedronate Sodium",{"EARLY_PHASE1":142,"PHASE1":144,"PHASE2":146,"PHASE3":158,"PHASE4":160,"NA":162},{"trials":143,"activeCount":54},[],{"trials":145,"activeCount":54},[],{"trials":147,"activeCount":54},[148],{"nctId":149,"briefTitle":150,"status":151,"phases":152,"primaryCompletion":153,"completion":153,"start":154,"enrollment":155,"conditions":156,"interventions":157},"NCT03208582","Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?","COMPLETED",[45],"2017-11-02","2017-04-01",13,[17],[140],{"trials":159,"activeCount":54},[],{"trials":161,"activeCount":54},[],{"trials":163,"activeCount":54},[],{"intervention":165,"totalTrials":9,"cells":166},"Clariom",{"EARLY_PHASE1":167,"PHASE1":169,"PHASE2":171,"PHASE3":173,"PHASE4":175,"NA":177},{"trials":168,"activeCount":54},[],{"trials":170,"activeCount":54},[],{"trials":172,"activeCount":54},[],{"trials":174,"activeCount":54},[],{"trials":176,"activeCount":54},[],{"trials":178,"activeCount":54},[179],{"nctId":180,"briefTitle":181,"status":130,"phases":182,"primaryCompletion":183,"completion":183,"start":184,"enrollment":54,"conditions":185,"interventions":186},"NCT04219111","Gene Expression Profiles in CML Non-responders",[],"2018-05-04","2017-10-01",[181],[165]]